Prevalence and management of hypertension in Type 1 diabetes mellitus in Europe: The Eurodiab IDDM Complications Study

F. Collado-Mesa, H. M. Colhoun, L. K. Stevens, J. Boavida, J. B. Ferriss, B. Karamanos, P. Kempler, G. Michel, G. Roglic, J. H. Fuller

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Aim: To examine the prevalence of hypertension and the rates of hypertension awareness by investigating treatment and control among respondents to the EURODIAB IDDM Complications Study, and to explore the variation in hypertension management by age, sex and end-organ damage. Methods: A cross-sectional study, examining 3250 randomly selected Type diabetic patients from 31 diabetes clinics in 16 European countries between 1989 and 1990. Mean age was 32.7 years (SD = 10.0) and mean duration of diabetes mellitus (DM) was 14.7 years (SD=9.3). Subjects were asked about a history of high blood pressure (BP) and current prescribed medications were recorded by the subject's physician. Hypertension was defined as having a systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg or current use of antihypertensives. Control was defined as a BP <130/85 mmHg. Results: Twenty-four per cent of subjects had hypertension, among whom fewer than one- half (48.5%) were aware of a previous diagnosis and a similar proportion (42.2%) were on treatment. Only 11.3% of those with hypertension were both treated and controlled. The majority (81%) of those receiving drug therapy for hypertension were on a single drug, most commonly an angiotensin- converting enzyme inhibitor (47%). Conclusion: These data show the extent of undermanagement of hypertension in Type 1 DM across Europe prior to the publication of the St. Vincent Declaration and provide a useful baseline against which future improvements in the management of hypertension can be monitored.

Original languageEnglish
Pages (from-to)41-49
Number of pages9
JournalDiabetic Medicine
Volume16
Issue number1
DOIs
Publication statusPublished - 1999

Fingerprint

Type 1 Diabetes Mellitus
Hypertension
Blood Pressure
Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents
Publications
Diabetes Mellitus
Cross-Sectional Studies
Physicians
Drug Therapy
Therapeutics

Keywords

  • Arterial hypertension
  • Awareness
  • Control
  • Prevalence
  • Treatment
  • Type 1 diabetes mellitus

ASJC Scopus subject areas

  • Endocrinology
  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Collado-Mesa, F., Colhoun, H. M., Stevens, L. K., Boavida, J., Ferriss, J. B., Karamanos, B., ... Fuller, J. H. (1999). Prevalence and management of hypertension in Type 1 diabetes mellitus in Europe: The Eurodiab IDDM Complications Study. Diabetic Medicine, 16(1), 41-49. https://doi.org/10.1046/j.1464-5491.1999.00007.x

Prevalence and management of hypertension in Type 1 diabetes mellitus in Europe : The Eurodiab IDDM Complications Study. / Collado-Mesa, F.; Colhoun, H. M.; Stevens, L. K.; Boavida, J.; Ferriss, J. B.; Karamanos, B.; Kempler, P.; Michel, G.; Roglic, G.; Fuller, J. H.

In: Diabetic Medicine, Vol. 16, No. 1, 1999, p. 41-49.

Research output: Contribution to journalArticle

Collado-Mesa, F, Colhoun, HM, Stevens, LK, Boavida, J, Ferriss, JB, Karamanos, B, Kempler, P, Michel, G, Roglic, G & Fuller, JH 1999, 'Prevalence and management of hypertension in Type 1 diabetes mellitus in Europe: The Eurodiab IDDM Complications Study', Diabetic Medicine, vol. 16, no. 1, pp. 41-49. https://doi.org/10.1046/j.1464-5491.1999.00007.x
Collado-Mesa, F. ; Colhoun, H. M. ; Stevens, L. K. ; Boavida, J. ; Ferriss, J. B. ; Karamanos, B. ; Kempler, P. ; Michel, G. ; Roglic, G. ; Fuller, J. H. / Prevalence and management of hypertension in Type 1 diabetes mellitus in Europe : The Eurodiab IDDM Complications Study. In: Diabetic Medicine. 1999 ; Vol. 16, No. 1. pp. 41-49.
@article{2729bc067e0147ff88a354bb3208a9af,
title = "Prevalence and management of hypertension in Type 1 diabetes mellitus in Europe: The Eurodiab IDDM Complications Study",
abstract = "Aim: To examine the prevalence of hypertension and the rates of hypertension awareness by investigating treatment and control among respondents to the EURODIAB IDDM Complications Study, and to explore the variation in hypertension management by age, sex and end-organ damage. Methods: A cross-sectional study, examining 3250 randomly selected Type diabetic patients from 31 diabetes clinics in 16 European countries between 1989 and 1990. Mean age was 32.7 years (SD = 10.0) and mean duration of diabetes mellitus (DM) was 14.7 years (SD=9.3). Subjects were asked about a history of high blood pressure (BP) and current prescribed medications were recorded by the subject's physician. Hypertension was defined as having a systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg or current use of antihypertensives. Control was defined as a BP <130/85 mmHg. Results: Twenty-four per cent of subjects had hypertension, among whom fewer than one- half (48.5{\%}) were aware of a previous diagnosis and a similar proportion (42.2{\%}) were on treatment. Only 11.3{\%} of those with hypertension were both treated and controlled. The majority (81{\%}) of those receiving drug therapy for hypertension were on a single drug, most commonly an angiotensin- converting enzyme inhibitor (47{\%}). Conclusion: These data show the extent of undermanagement of hypertension in Type 1 DM across Europe prior to the publication of the St. Vincent Declaration and provide a useful baseline against which future improvements in the management of hypertension can be monitored.",
keywords = "Arterial hypertension, Awareness, Control, Prevalence, Treatment, Type 1 diabetes mellitus",
author = "F. Collado-Mesa and Colhoun, {H. M.} and Stevens, {L. K.} and J. Boavida and Ferriss, {J. B.} and B. Karamanos and P. Kempler and G. Michel and G. Roglic and Fuller, {J. H.}",
year = "1999",
doi = "10.1046/j.1464-5491.1999.00007.x",
language = "English",
volume = "16",
pages = "41--49",
journal = "Diabetic Medicine",
issn = "0742-3071",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Prevalence and management of hypertension in Type 1 diabetes mellitus in Europe

T2 - The Eurodiab IDDM Complications Study

AU - Collado-Mesa, F.

AU - Colhoun, H. M.

AU - Stevens, L. K.

AU - Boavida, J.

AU - Ferriss, J. B.

AU - Karamanos, B.

AU - Kempler, P.

AU - Michel, G.

AU - Roglic, G.

AU - Fuller, J. H.

PY - 1999

Y1 - 1999

N2 - Aim: To examine the prevalence of hypertension and the rates of hypertension awareness by investigating treatment and control among respondents to the EURODIAB IDDM Complications Study, and to explore the variation in hypertension management by age, sex and end-organ damage. Methods: A cross-sectional study, examining 3250 randomly selected Type diabetic patients from 31 diabetes clinics in 16 European countries between 1989 and 1990. Mean age was 32.7 years (SD = 10.0) and mean duration of diabetes mellitus (DM) was 14.7 years (SD=9.3). Subjects were asked about a history of high blood pressure (BP) and current prescribed medications were recorded by the subject's physician. Hypertension was defined as having a systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg or current use of antihypertensives. Control was defined as a BP <130/85 mmHg. Results: Twenty-four per cent of subjects had hypertension, among whom fewer than one- half (48.5%) were aware of a previous diagnosis and a similar proportion (42.2%) were on treatment. Only 11.3% of those with hypertension were both treated and controlled. The majority (81%) of those receiving drug therapy for hypertension were on a single drug, most commonly an angiotensin- converting enzyme inhibitor (47%). Conclusion: These data show the extent of undermanagement of hypertension in Type 1 DM across Europe prior to the publication of the St. Vincent Declaration and provide a useful baseline against which future improvements in the management of hypertension can be monitored.

AB - Aim: To examine the prevalence of hypertension and the rates of hypertension awareness by investigating treatment and control among respondents to the EURODIAB IDDM Complications Study, and to explore the variation in hypertension management by age, sex and end-organ damage. Methods: A cross-sectional study, examining 3250 randomly selected Type diabetic patients from 31 diabetes clinics in 16 European countries between 1989 and 1990. Mean age was 32.7 years (SD = 10.0) and mean duration of diabetes mellitus (DM) was 14.7 years (SD=9.3). Subjects were asked about a history of high blood pressure (BP) and current prescribed medications were recorded by the subject's physician. Hypertension was defined as having a systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg or current use of antihypertensives. Control was defined as a BP <130/85 mmHg. Results: Twenty-four per cent of subjects had hypertension, among whom fewer than one- half (48.5%) were aware of a previous diagnosis and a similar proportion (42.2%) were on treatment. Only 11.3% of those with hypertension were both treated and controlled. The majority (81%) of those receiving drug therapy for hypertension were on a single drug, most commonly an angiotensin- converting enzyme inhibitor (47%). Conclusion: These data show the extent of undermanagement of hypertension in Type 1 DM across Europe prior to the publication of the St. Vincent Declaration and provide a useful baseline against which future improvements in the management of hypertension can be monitored.

KW - Arterial hypertension

KW - Awareness

KW - Control

KW - Prevalence

KW - Treatment

KW - Type 1 diabetes mellitus

UR - http://www.scopus.com/inward/record.url?scp=0033015648&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033015648&partnerID=8YFLogxK

U2 - 10.1046/j.1464-5491.1999.00007.x

DO - 10.1046/j.1464-5491.1999.00007.x

M3 - Article

C2 - 10229292

AN - SCOPUS:0033015648

VL - 16

SP - 41

EP - 49

JO - Diabetic Medicine

JF - Diabetic Medicine

SN - 0742-3071

IS - 1

ER -